Jessica A. Flynn

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

Vamsee Mallajosyula, Michael Citron, Francesca Ferrara et al. · Proceedings of the National Academy of Sciences · 2014 · 198 citations · Full text

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection

Amy S. Espeseth, Pedro J. Cejas, Michael Citron et al. · npj Vaccines · 2020 · 178 citations · Full text

Discovery of 3-{5-[(6-Amino-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses

Thomas J. Tucker, John T. Sisko, Robert M. Tynebor et al. · Journal of Medicinal Chemistry · 2008 · 132 citations · Full text

Molecular Biology, Key Mutant Viruses, Pharmacotherapy +20

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Sita Awasthi, John M. Lubinski, Carolyn E. Shaw et al. · Journal of Virology · 2011 · 81 citations · Full text

Veterinary Vaccine, Hsv-2 Dna, Immunology +20

The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutations

Thomas J. Tucker, Sandeep Saggar, John T. Sisko et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 60 citations · Full text

Medicinal Chemistry, Medicine, Natural Sciences +12